Quest Diagnostics Revenue 2010-2024 | DGX

Quest Diagnostics revenue for the twelve months ending September 30, 2024 was $9.539B, a 2.6% increase year-over-year.

  • Quest Diagnostics annual revenue for 2023 was $9.252B, a 6.38% decline from 2022.
  • Quest Diagnostics annual revenue for 2022 was $9.883B, a 8.39% decline from 2021.
  • Quest Diagnostics annual revenue for 2021 was $10.788B, a 14.32% increase from 2020.

Quest Diagnostics Revenue 2010-2024 | DGX

  • Quest Diagnostics annual revenue for 2023 was $9.252B, a 6.38% decline from 2022.
  • Quest Diagnostics annual revenue for 2022 was $9.883B, a 8.39% decline from 2021.
  • Quest Diagnostics annual revenue for 2021 was $10.788B, a 14.32% increase from 2020.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$19.5B
DaVita (DVA)$13.6B
Encompass Health (EHC)$10.2B
Chemed (CHE)$8.6B
Elanco Animal Health (ELAN)$6.6B
RadNet (RDNT)$6.1B
Option Care Health (OPCH)$3.9B
Amedisys (AMED)$3B
LifeStance Health (LFST)$2.8B
Astrana Health (ASTH)$2.4B
Addus HomeCare (ADUS)$2.3B
U.S Physical Therapy (USPH)$1.5B
Aveanna Healthcare Holdings (AVAH)$1.1B
Pennant (PNTG)$1.1B
Atai Life Sciences (ATAI)$270M
Daxor (DXR)$45M
Psychemedics (PMD)$14M
MEDIROM Healthcare Technologies (MRM)$14M
ATI Physical Therapy (ATIP)$8M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M